Personal tools

Coexpression cluster:C138

From FANTOM5_SSTAR

Revision as of 14:10, 21 May 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C138_diffuse_Burkitt_lymphangiectasia_lymphoma_acute_CD19_pineal



Phase1 CAGE Peaks

Hg19::chr10:560037..560049,-p@chr10:560037..560049
-
Hg19::chr11:111224906..111224920,-p@chr11:111224906..111224920
-
Hg19::chr11:111229505..111229516,-p@chr11:111229505..111229516
-
Hg19::chr11:2407318..2407325,+p24@CD81
Hg19::chr11:2407761..2407778,+p26@CD81
Hg19::chr11:26122006..26122011,-p@chr11:26122006..26122011
-
Hg19::chr11:26124040..26124064,-p@chr11:26124040..26124064
-
Hg19::chr12:113494494..113494505,+p4@DTX1
Hg19::chr12:113494516..113494577,+p1@DTX1
Hg19::chr12:113495162..113495172,+p11@DTX1
Hg19::chr12:113495245..113495253,+p5@DTX1
Hg19::chr12:113495715..113495725,+p8@DTX1
Hg19::chr12:113496099..113496108,+p3@AB384763
Hg19::chr12:113496125..113496146,+p1@AB384763
Hg19::chr12:113533128..113533138,+p@chr12:113533128..113533138
+
Hg19::chr12:117256221..117256231,+p@chr12:117256221..117256231
+
Hg19::chr12:117256250..117256271,+p@chr12:117256250..117256271
+
Hg19::chr12:117256273..117256285,+p@chr12:117256273..117256285
+
Hg19::chr12:11905315..11905321,+p30@ETV6
Hg19::chr12:11905335..11905342,+p28@ETV6
Hg19::chr12:122435304..122435308,-p@chr12:122435304..122435308
-
Hg19::chr12:122458855..122458857,+p16@BCL7A
Hg19::chr12:122459183..122459198,+p10@BCL7A
Hg19::chr12:122459199..122459208,+p13@BCL7A
Hg19::chr12:122462311..122462330,-p@chr12:122462311..122462330
-
Hg19::chr12:122462770..122462775,+p@chr12:122462770..122462775
+
Hg19::chr12:2296602..2296621,+p@chr12:2296602..2296621
+
Hg19::chr12:4313305..4313315,+p@chr12:4313305..4313315
+
Hg19::chr12:4313331..4313334,+p@chr12:4313331..4313334
+
Hg19::chr12:8808206..8808209,-p@chr12:8808206..8808209
-
Hg19::chr12:94551874..94551884,+p16@PLXNC1
Hg19::chr13:103821459..103821470,+p@chr13:103821459..103821470
+
Hg19::chr13:61236926..61236943,+p@chr13:61236926..61236943
+
Hg19::chr14:106332392..106332397,-p@chr14:106332392..106332397
-
Hg19::chr14:106332402..106332439,-p@chr14:106332402..106332439
-
Hg19::chr14:106332443..106332451,-p@chr14:106332443..106332451
-
Hg19::chr14:106332453..106332464,-p@chr14:106332453..106332464
-
Hg19::chr14:106332480..106332490,-p@chr14:106332480..106332490
-
Hg19::chr14:106332501..106332515,-p@chr14:106332501..106332515
-
Hg19::chr14:106332518..106332527,-p@chr14:106332518..106332527
-
Hg19::chr14:106332629..106332637,-p@chr14:106332629..106332637
-
Hg19::chr14:33433362..33433367,-p@chr14:33433362..33433367
-
Hg19::chr14:33449602..33449615,-p@chr14:33449602..33449615
-
Hg19::chr14:53594794..53594799,+p@chr14:53594794..53594799
+
Hg19::chr14:75906948..75906962,+p@chr14:75906948..75906962
+
Hg19::chr14:91750002..91750014,-p21@CCDC88C
Hg19::chr14:96152757..96152769,+p1@TCL1B
Hg19::chr14:96181789..96181822,+p1@ENST00000556386
p1@uc001yfd.1
Hg19::chr14:96181832..96181839,+p2@uc001yfd.1
Hg19::chr14:96184093..96184099,+p@chr14:96184093..96184099
+
Hg19::chr15:66446160..66446166,-p@chr15:66446160..66446166
-
Hg19::chr15:66446174..66446184,-p@chr15:66446174..66446184
-
Hg19::chr15:66446191..66446202,-p@chr15:66446191..66446202
-
Hg19::chr15:66464730..66464736,-p@chr15:66464730..66464736
-
Hg19::chr15:67841330..67841348,+p4@MAP2K5
Hg19::chr15:84653070..84653073,+p@chr15:84653070..84653073
+
Hg19::chr16:86604624..86604648,+p@chr16:86604624..86604648
+
Hg19::chr16:87098907..87098937,-p@chr16:87098907..87098937
-
Hg19::chr17:3123719..3123724,-p@chr17:3123719..3123724
-
Hg19::chr17:74846230..74846245,+p1@uc002jtf.2
Hg19::chr17:74965032..74965049,-p@chr17:74965032..74965049
-
Hg19::chr17:74965255..74965298,-p1@AK123869
Hg19::chr18:3174522..3174533,-p@chr18:3174522..3174533
-
Hg19::chr18:71693057..71693059,-p@chr18:71693057..71693059
-
Hg19::chr18:71733441..71733451,-p@chr18:71733441..71733451
-
Hg19::chr19:29097532..29097550,+p@chr19:29097532..29097550
+
Hg19::chr19:29098223..29098234,+p@chr19:29098223..29098234
+
Hg19::chr1:160414041..160414045,-p@chr1:160414041..160414045
-
Hg19::chr1:167666666..167666680,+p4@RCSD1
Hg19::chr1:171125500..171125502,-p@chr1:171125500..171125502
-
Hg19::chr1:178636283..178636287,+p@chr1:178636283..178636287
+
Hg19::chr22:23234780..23234786,+p@chr22:23234780..23234786
+
Hg19::chr22:23235755..23235760,+p@chr22:23235755..23235760
+
Hg19::chr22:23235843..23235863,+p1@IGLJ1
Hg19::chr22:23235880..23235915,+p2@AK097035
Hg19::chr22:23235933..23235972,+p1@AK097035
Hg19::chr2:198220285..198220289,-p@chr2:198220285..198220289
-
Hg19::chr2:198220897..198220904,-p@chr2:198220897..198220904
-
Hg19::chr2:89162159..89162169,-p@chr2:89162159..89162169
-
Hg19::chr2:98534317..98534328,-p@chr2:98534317..98534328
-
Hg19::chr3:153480361..153480373,-p1@ENST00000493214
Hg19::chr3:19436672..19436686,+p@chr3:19436672..19436686
+
Hg19::chr3:62809350..62809370,+p@chr3:62809350..62809370
+
Hg19::chr3:77626663..77626683,+p@chr3:77626663..77626683
+
Hg19::chr4:176346295..176346296,-p@chr4:176346295..176346296
-
Hg19::chr4:176353908..176353917,-p@chr4:176353908..176353917
-
Hg19::chr4:176358284..176358287,-p@chr4:176358284..176358287
-
Hg19::chr4:71532616..71532662,-p5@IGJ
Hg19::chr4:8046897..8046900,+p@chr4:8046897..8046900
+
Hg19::chr4:8046990..8046993,-p@chr4:8046990..8046993
-
Hg19::chr4:86525299..86525314,+p27@ARHGAP24
Hg19::chr4:86525321..86525343,+p19@ARHGAP24
Hg19::chr4:86525345..86525360,+p17@ARHGAP24
Hg19::chr5:118755330..118755335,+p@chr5:118755330..118755335
+
Hg19::chr6:184352..184384,-p@chr6:184352..184384
-
Hg19::chr6:26220614..26220622,-p@chr6:26220614..26220622
-
Hg19::chr6:39962285..39962290,+p@chr6:39962285..39962290
+
Hg19::chr6:39962295..39962305,+p@chr6:39962295..39962305
+
Hg19::chr6:39962337..39962342,+p@chr6:39962337..39962342
+
Hg19::chr6:89324309..89324332,-p@chr6:89324309..89324332
-
Hg19::chr6:89324350..89324357,-p@chr6:89324350..89324357
-
Hg19::chr7:44140835..44140864,+p@chr7:44140835..44140864
+
Hg19::chr7:47131937..47131939,-p@chr7:47131937..47131939
-
Hg19::chr7:47143537..47143540,-p@chr7:47143537..47143540
-
Hg19::chr7:47143563..47143572,-p@chr7:47143563..47143572
-
Hg19::chr7:47225953..47225964,-p@chr7:47225953..47225964
-
Hg19::chr7:47225965..47225970,-p@chr7:47225965..47225970
-
Hg19::chr7:47226019..47226026,-p@chr7:47226019..47226026
-
Hg19::chr7:47226094..47226108,-p@chr7:47226094..47226108
-
Hg19::chr8:103211732..103211741,-p@chr8:103211732..103211741
-
Hg19::chr8:54811712..54811719,+p1@ENST00000508149
Hg19::chr8:9577966..9577972,+p26@TNKS
Hg19::chr8:9577986..9578004,+p12@TNKS
Hg19::chr8:9578005..9578014,+p22@TNKS
Hg19::chr9:120707790..120707797,-p@chr9:120707790..120707797
-
Hg19::chr9:120707817..120707824,-p@chr9:120707817..120707824
-
Hg19::chr9:138904824..138904829,+p@chr9:138904824..138904829
+
Hg19::chr9:71805723..71805737,+p@chr9:71805723..71805737
+
Hg19::chr9:96029287..96029296,+p15@WNK2
Hg19::chr9:96029313..96029322,+p9@WNK2
Hg19::chr9:96030923..96030932,-p@chr9:96030923..96030932
-
Hg19::chr9:96030936..96030946,-p@chr9:96030936..96030946
-
Hg19::chr9:96059957..96059996,+p@chr9:96059957..96059996
+
Hg19::chrX:42727011..42727017,-p@chrX:42727011..42727017
-
Hg19::chrX:42727038..42727047,-p@chrX:42727038..42727047
-
Hg19::chrX:42727059..42727068,-p@chrX:42727059..42727068
-
Hg19::chrX:47051618..47051644,+p@chrX:47051618..47051644
+
Hg19::chrX:47051652..47051664,+p@chrX:47051652..47051664
+
Hg19::chrX:89012355..89012363,+p@chrX:89012355..89012363
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0006468protein amino acid phosphorylation0.00792695412488815
GO:0016310phosphorylation0.00792695412488815
GO:0001932regulation of protein amino acid phosphorylation0.00792695412488815
GO:0033238regulation of amine metabolic process0.00792695412488815
GO:0006521regulation of amino acid metabolic process0.00792695412488815
GO:0042325regulation of phosphorylation0.00841869775108913
GO:0006793phosphorus metabolic process0.00841869775108913
GO:0006796phosphate metabolic process0.00841869775108913
GO:0051174regulation of phosphorus metabolic process0.00841869775108913
GO:0019220regulation of phosphate metabolic process0.00841869775108913
GO:0043126regulation of 1-phosphatidylinositol 4-kinase activity0.00841869775108913
GO:0043128positive regulation of 1-phosphatidylinositol 4-kinase activity0.00841869775108913
GO:0046813virion attachment, binding of host cell surface receptor0.00841869775108913
GO:0031648protein destabilization0.0156319629705365
GO:0018193peptidyl-amino acid modification0.0172743813151962
GO:0043687post-translational protein modification0.0172743813151962
GO:0018210peptidyl-threonine modification0.0172743813151962
GO:0018107peptidyl-threonine phosphorylation0.0172743813151962
GO:0019062virion attachment to host cell surface receptor0.0172743813151962
GO:0007165signal transduction0.0191047159318527
GO:0008593regulation of Notch signaling pathway0.0202675609349334
GO:0005515protein binding0.0202675609349334
GO:0007154cell communication0.0266769412154499
GO:0006661phosphatidylinositol biosynthetic process0.0272081182847486
GO:0006464protein modification process0.0272081182847486
GO:0043550regulation of lipid kinase activity0.0294342336391061
GO:0043412biopolymer modification0.0300437386506703
GO:0005112Notch binding0.0300437386506703
GO:0043621protein self-association0.0300437386506703
GO:0018209peptidyl-serine modification0.0300437386506703
GO:0018105peptidyl-serine phosphorylation0.0300437386506703
GO:0044409entry into host0.0300437386506703
GO:0045665negative regulation of neuron differentiation0.0300437386506703
GO:0052192movement in environment of other organism during symbiotic interaction0.0300437386506703
GO:0046718entry of virus into host cell0.0300437386506703
GO:0030260entry into host cell0.0300437386506703
GO:0019059initiation of viral infection0.0300437386506703
GO:0052126movement in host environment0.0300437386506703
GO:0051828entry into other organism during symbiotic interaction0.0300437386506703
GO:0051806entry into cell of other organism during symbiotic interaction0.0300437386506703
GO:0007004telomere maintenance via telomerase0.0441734036898593
GO:0050731positive regulation of peptidyl-tyrosine phosphorylation0.0441734036898593
GO:0030165PDZ domain binding0.0495802336358574
GO:0005626insoluble fraction0.0495802336358574



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Uber Anatomy
Ontology termp-valuen
adult organism1.93e-35115
central nervous system4.35e-1882
neural tube3.30e-1757
neural rod3.30e-1757
future spinal cord3.30e-1757
neural keel3.30e-1757
regional part of nervous system5.22e-1694
nervous system5.22e-1694
anterior neural tube2.02e-1442
regional part of brain5.32e-1459
regional part of forebrain6.00e-1441
forebrain6.00e-1441
future forebrain6.00e-1441
brain7.06e-1469
future brain7.06e-1469
gray matter1.09e-1134
brain grey matter1.09e-1134
telencephalon1.31e-1134
cerebral hemisphere2.89e-1132
regional part of telencephalon3.84e-1133
regional part of cerebral cortex1.02e-0922
cerebral cortex2.90e-0925
pallium2.90e-0925
neocortex3.32e-0920
neurectoderm2.73e-0890
neural plate9.20e-0886
presumptive neural plate9.20e-0886
Disease
Ontology termp-valuen
hematologic cancer5.33e-0951
immune system cancer5.33e-0951


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.